spacer
home > epc > summer 2019 > overcoming the industry data crisis
PUBLICATIONS
European Pharmaceutical Contractor

Overcoming the Industry Data Crisis




The amount of data generated around the world is growing exponentially and at rates that are so great they are difficult to grasp. By one calculation, 90% of the world’s data have been generated over the last two years (1). To put it in terms used by the International Data Corporation in its estimates: by 2025, the global datasphere will reach 175 zettabytes − the equivalent of 175 trillion gigabytes (2).

With data from the newest technologies, applications, devices, and wearables all contributing, the sheer breadth of available information in clinical research is staggering, and its potential for contributing positively to modernisation is virtually limitless. The pharmaceutical industry has progressively accepted electronic data capture (EDC) as the standard practice for clinical trials. Overall, the adoption of EDC has resulted in some improvement across the industry − relative to antiquated paper processes − but EDC still largely relies on paper-based source documents (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

 
Ed Seguine, CEO at Clinical Ink, is passionate about creating solutions for problems caused by current clinical trial processes and technologies. With more than 20 years of experience as a clinical technology executive at Big Pharma and startup organisations, Ed, a thought leader on key initiatives including CDISC and eClinical Forum, often presents at industry events and publishes regularly on the benefits of next-generation eSource solutions. He earned a Master of Business Administration from Indiana University, Bloomington, US, and a Bachelor of Science in Finance from Brigham Young University, US.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement